GSK4527226 (AL101)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GSK4527226 (AL101), covering 2025-11-14 to 2025-11-14. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety of GSK4527226 [AL101] in Participants With Early Alzheimer's Disease [Phase 2]